The Doxycycline Hyclate Tablets, cataloged under National Stock Number 6505-01-687-1016, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Chartwell Rx Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-687-1016 |
| Primary Part Number | NDC62135-0626-28 |
| Item Name | Doxycycline Hyclate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Chartwell Rx Llc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 28.0 TABLETS |
| Features Provided | CHILD RESISTANT CLOSURE |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC62135-0626-28 | Dms Pharmaceutical Group Inc (USA) |
| NDC62135-0626-28 PRIMARY | Chartwell Rx Llc (USA) |
| 896680 | Dms Pharmaceutical Group Inc (USA) |
| Reference | Meaning |
|---|---|
| DOXYCYCLINE | 5/1 Secondary reference Chartwell Rx Llc |
| 6505NCM205957 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1567869 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-687-1016 is a Doxycycline Hyclate Tablets, manufactured by Chartwell Rx Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-687-1016 has 3 manufacturer part numbers on file: NDC62135-0626-28 (Dms Pharmaceutical Group Inc), NDC62135-0626-28 (Chartwell Rx Llc), 896680 (Dms Pharmaceutical Group Inc).
Key specifications for NDC62135-0626-28: Administration: ORAL; Primary Container Content Quantity: 28.0 TABLETS; Features Provided: CHILD RESISTANT CLOSURE; Primary Container Type: BOTTLE. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.